These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 36747819)

  • 1. Cross-species transcriptomic analysis identifies mitochondrial dysregulation as a functional consequence of the schizophrenia-associated 3q29 deletion.
    Purcell RH; Sefik E; Werner E; King AT; Mosley TJ; Merritt-Garza ME; Chopra P; McEachin ZT; Karne S; Raj N; Vaglio BJ; Sullivan D; Firestein BL; Tilahun K; Robinette MI; Warren ST; Wen Z; Faundez V; Sloan SA; Bassell GJ; Mulle JG
    bioRxiv; 2023 May; ():. PubMed ID: 36747819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-species analysis identifies mitochondrial dysregulation as a functional consequence of the schizophrenia-associated 3q29 deletion.
    Purcell RH; Sefik E; Werner E; King AT; Mosley TJ; Merritt-Garza ME; Chopra P; McEachin ZT; Karne S; Raj N; Vaglio BJ; Sullivan D; Firestein BL; Tilahun K; Robinette MI; Warren ST; Wen Z; Faundez V; Sloan SA; Bassell GJ; Mulle JG
    Sci Adv; 2023 Aug; 9(33):eadh0558. PubMed ID: 37585521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Convergent and distributed effects of the 3q29 deletion on the human neural transcriptome.
    Sefik E; Purcell RH; ; Walker EF; Bassell GJ; Mulle JG
    Transl Psychiatry; 2021 Jun; 11(1):357. PubMed ID: 34131099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autism spectrum disorder symptom expression in individuals with 3q29 deletion syndrome.
    Pollak RM; Pincus JE; Burrell TL; Cubells JF; Klaiman C; Murphy MM; Saulnier CA; Walker EF; White SP; Mulle JG
    Mol Autism; 2022 Dec; 13(1):50. PubMed ID: 36566217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropsychiatric phenotypes and a distinct constellation of ASD features in 3q29 deletion syndrome: results from the 3q29 registry.
    Pollak RM; Murphy MM; Epstein MP; Zwick ME; Klaiman C; Saulnier CA; ; Mulle JG
    Mol Autism; 2019; 10():30. PubMed ID: 31346402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioral Phenotypes and Comorbidity in 3q29 Deletion Syndrome: Results from the 3q29 Registry.
    Pollak RM; Mortillo M; Murphy MM; Mulle JG
    J Autism Dev Disord; 2024 Jan; ():. PubMed ID: 38216835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Musculoskeletal phenotypes in 3q29 deletion syndrome.
    Pollak RM; Tilmon JC; Murphy MM; Gambello MJ; Sanchez Russo R; Dormans JP; Mulle JG
    Am J Med Genet A; 2023 Nov; 191(11):2749-2756. PubMed ID: 37691301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychosis spectrum symptoms among individuals with schizophrenia-associated copy number variants and evidence of cerebellar correlates of symptom severity.
    Sefik E; Guest RM; Aberizk K; Espana R; Goines K; Novacek DM; Murphy MM; Goldman-Yassen AE; Cubells JF; Ousley O; Li L; Shultz S; Walker EF; Mulle JG
    Psychiatry Res; 2024 May; 335():115867. PubMed ID: 38537595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visual-Motor Integration Deficits in 3q29 Deletion Syndrome.
    Pollak RM; Burrell TL; Cubells JF; Klaiman C; Murphy MM; Saulnier CA; Walker EF; White SP; Mulle JG
    J Autism Dev Disord; 2024 Aug; 54(8):3142-3154. PubMed ID: 37354284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Musculoskeletal phenotypes in 3q29 deletion syndrome.
    Pollak RM; Tilmon JC; Murphy MM; Gambello MJ; Russo RS; Dormans JP; Mulle JG
    medRxiv; 2023 Apr; ():. PubMed ID: 37066183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic effects of the schizophrenia-associated 3q29 deletion.
    Pollak RM; Purcell RH; Rutkowski TP; Malone T; Pachura KJ; Bassell GJ; Epstein MP; Dawson PA; Smith MR; Jones DP; Zwick ME; Warren ST; Caspary T; Weinshenker D; Mulle JG
    Transl Psychiatry; 2022 Feb; 12(1):66. PubMed ID: 35177588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal Transcriptomic Analysis of Human Cortical Spheroids Identifies Axonal Dysregulation in the Prenatal Brain as a Mediator of Genetic Risk for Schizophrenia.
    Akkouh IA; Ueland T; Szabo A; Hughes T; Smeland OB; Andreassen OA; Osete JR; Djurovic S
    Biol Psychiatry; 2024 Apr; 95(7):687-698. PubMed ID: 37661009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Craniofacial features of 3q29 deletion syndrome: Application of next-generation phenotyping technology.
    Mak BC; Sanchez Russo R; Gambello MJ; Fleischer N; Black ED; Leslie E; Murphy MM; ; Mulle JG
    Am J Med Genet A; 2021 Jul; 185(7):2094-2101. PubMed ID: 33938623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychiatric-disorder-related behavioral phenotypes and cortical hyperactivity in a mouse model of 3q29 deletion syndrome.
    Baba M; Yokoyama K; Seiriki K; Naka Y; Matsumura K; Kondo M; Yamamoto K; Hayashida M; Kasai A; Ago Y; Nagayasu K; Hayata-Takano A; Takahashi A; Yamaguchi S; Mori D; Ozaki N; Yamamoto T; Takuma K; Hashimoto R; Hashimoto H; Nakazawa T
    Neuropsychopharmacology; 2019 Nov; 44(12):2125-2135. PubMed ID: 31216562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adaptive behaviour deficits in individuals with 3q29 deletion syndrome.
    Pollak RM; Burrell TL; Cubells JF; Klaiman C; Murphy MM; Saulnier CA; Walker EF; White SP; Mulle JG
    J Intellect Disabil Res; 2024 Feb; 68(2):113-127. PubMed ID: 37740553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptomic Landscape and Functional Characterization of Induced Pluripotent Stem Cell-Derived Cerebral Organoids in Schizophrenia.
    Kathuria A; Lopez-Lengowski K; Jagtap SS; McPhie D; Perlis RH; Cohen BM; Karmacharya R
    JAMA Psychiatry; 2020 Jul; 77(7):745-754. PubMed ID: 32186681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adaptive behavior deficits in individuals with 3q29 deletion syndrome.
    Pollak RM; Burrell TL; Cubells JF; Klaiman C; Murphy MM; Saulnier CA; Walker EF; White SP; Mulle JG
    medRxiv; 2023 Apr; ():. PubMed ID: 37066139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural deviations of the posterior fossa and the cerebellum and their cognitive links in a neurodevelopmental deletion syndrome.
    Sefik E; Duan K; Li Y; Sholar B; Evans L; Pincus J; Ammar Z; Murphy MM; Klaiman C; Saulnier CA; Pulver SL; Goldman-Yassen AE; Guo Y; Walker EF; Li L; Mulle JG; Shultz S
    Mol Psychiatry; 2024 May; ():. PubMed ID: 38744992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Excitatory Dysfunction Drives Network and Calcium Handling Deficits in 16p11.2 Duplication Schizophrenia Induced Pluripotent Stem Cell-Derived Neurons.
    Parnell E; Culotta L; Forrest MP; Jalloul HA; Eckman BL; Loizzo DD; Horan KKE; Dos Santos M; Piguel NH; Tai DJC; Zhang H; Gertler TS; Simkin D; Sanders AR; Talkowski ME; Gejman PV; Kiskinis E; Duan J; Penzes P
    Biol Psychiatry; 2023 Jul; 94(2):153-163. PubMed ID: 36581494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular brain (micro report) oxytocin ameliorates impaired social behavior in a mouse model of 3q29 deletion syndrome.
    Takemoto T; Baba M; Yokoyama K; Kitagawa K; Nagayasu K; Ago Y; Seiriki K; Hayata-Takano A; Kasai A; Mori D; Ozaki N; Takuma K; Hashimoto R; Hashimoto H; Nakazawa T
    Mol Brain; 2022 Mar; 15(1):26. PubMed ID: 35346312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.